A participação do paciente é essencial para o sucesso dos estudos clínicos, mas o impacto econômico é frequentemente subestimado.

In this exclusive webinar, Robin Marcus, Marken’s Head of Global Decentralized Trials Market Development, explores the comprehensive financial effects of patient engagement, from the costs incurred by participants to the wider economic consequences for sponsors and the healthcare system. 

You’ll learn how Marken’s patient-centric solutions, such as home healthcare and direct-to-patient services, can ease these financial burdens, boost recruitment and retention, accelerate trial timelines, and reduce overall expenses. 

Watch to see how prioritizing the patient experience drives more efficient, cost-effective clinical trials while improving outcomes for all stakeholders